Alchemy is building materials science platforms capable of solving emerging performance problems
across multiple industries.

Long Form Prospectus

Our solutions are built around proprietary nanotechnologies designed to enhance durability, manage thermal signatures, and improve material performance in demanding environments.

Defence

Alchemy’s defense business unit, Crypsis™, is focused on a nanoparticle-based thermal signature management (TSM) platform designed to reduce thermal detectability in modern sensor-rich battlefields.

Automotive

ExoShield is an automotive protection platform designed to eliminate windshield damage. Built on Alchemy’s proprietary materials, the film provides a resilient, impact-resistant layer that maintains the high-definition clarity required for modern windshield sensors and ADAS.

Team

Khanjan Desai
CEO;GM, Defence

Nanotechnology @ UWaterloo, Harvard, Facebook, Forbes 30u30

Doug Lawson
CFO

42 Years in financial leadership
CEO @ NAFA; VP @ Molson

Danielle Smiley
GM, Automotive

PhD @ McMaster University
Lab2Market Growth Coach

Board of Directors

Paul Andreola

Director

Early XPEL Investor, NameSilo SmallCap Discoveries

LinkedIn

David Mes

Director, Chairman

Private Equity Leader, Eren Groupe, OTG Ventures, Wharton Alumni

LinkedIn

Michel-Henry St Louis

Director

Retired Maj Gen Canadian Army & Former Defence Attaché to US Army

LinkedIn

Peter Hatges

Director

KPMG Automotive Sector Leader Chair, Americas Corporate Finance

LinkedIn

Rahul Petkar

Director

Polaris Canada, TD Waterhouse, Citibank, Merrill Lynch

LinkedIn

Subscribe

* indicates required

Investor Enquiries

For all investor queries, please reach out to us directly at investors@alchemynano.com

Recent Press

FAQ

How do I purchase Alchemy’s shares?

Alchemy shares can be purchased through most Canadian investment dealers and online brokerage platforms that provide access to the TSX Venture Exchange. Investors should contact their broker or financial advisor for information regarding the purchase or sale of Alchemy shares.

When is Alchemy’s year-end?

Alchemy’s fiscal year aligns with the calendar year, ending on December 31.

Where can I get access to Alchemy’s public filings?

Alchemy’s regulatory filings, including financial statements, management’s discussion and analysis (MD&A), material change reports and other continuous disclosure documents, are available through SEDAR+, the official filing system for Canadian public companies. Key corporate documents and financial information are also available in the Investors section of Alchemy’s website.

How can I receive email updates from Alchemy?

To receive Alchemy Investor updates, subscribe to our IR mailing list through the submission form on the Alchemy Investor Page.

https://www.alchemynano.com/investors

When and where is Alchemy’s Annual Meeting of Shareholders? What do I need to be admitted?

Details regarding Alchemy’s Annual Meeting of Shareholders, including the date, time, location or virtual access information, are provided each year in the Company’s meeting materials and management information circular. These materials also provide instructions regarding shareholder participation, voting and any requirements for attending the meeting. Meeting materials are made available through Alchemy’s website and the Company’s profile on SEDAR+.

Who is Alchemy’s stock transfer agent for Canadian documentation?

Endeavour Trust, acts as Alchemy’s transfer agent and registrar in Canada. Registered shareholders should contact the transfer agent regarding share certificates, changes of address, estate transfers and other shareholder record matters.

Where can I find Alchemy’s Investor Presentation?

Alchemy's Investor Presentation is available for review or download on the Investor Page of Alchemy's website.

https://www.alchemynano.com/investors

Where are Alchemy’s shares traded?

Alchemy Labs Inc.’s common shares are listed on the TSX Venture Exchange (TSXV) under the trading symbol “ALCH.”